Unknown

Dataset Information

0

Identification of novel mutations responsible for resistance to MK-2048, a second-generation HIV-1 integrase inhibitor.


ABSTRACT: MK-2048 represents a prototype second-generation integrase strand transfer inhibitor (INSTI) developed with the goal of retaining activity against viruses containing mutations associated with resistance to first-generation INSTIs, raltegravir (RAL) and elvitegravir (EVG). Here, we report the identification of mutations (G118R and E138K) which confer resistance to MK-2048 and not to RAL or EVG. These mutations were selected in vitro and confirmed by site-specific mutagenesis. G118R, which appeared first in cell culture, conferred low levels of resistance to MK-2048. G118R also reduced viral replication capacity to approximately 1% that of the isogenic wild-type (wt) virus. The subsequent selection of E138K partially restored replication capacity to approximately 13% of wt levels and increased resistance to MK-2048 to approximately 8-fold. Viruses containing G118R and E138K remained largely susceptible to both RAL and EVG, suggesting a unique interaction between this second-generation INSTI and the enzyme may be defined by these residues as a potential basis for the increased intrinsic affinity and longer "off" rate of MK-2048. In silico structural analysis suggests that the introduction of a positively charged arginine at position 118, near the catalytic amino acid 116, might decrease Mg(2+) binding, compromising enzyme function and thus leading to the significant reduction in both integration and viral replication capacity observed with these mutations.

SUBMITTER: Bar-Magen T 

PROVIDER: S-EPMC2937597 | biostudies-literature | 2010 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Identification of novel mutations responsible for resistance to MK-2048, a second-generation HIV-1 integrase inhibitor.

Bar-Magen Tamara T   Sloan Richard D RD   Donahue Daniel A DA   Kuhl Björn D BD   Zabeida Alexandra A   Xu Hongtao H   Oliveira Maureen M   Hazuda Daria J DJ   Wainberg Mark A MA  

Journal of virology 20100707 18


MK-2048 represents a prototype second-generation integrase strand transfer inhibitor (INSTI) developed with the goal of retaining activity against viruses containing mutations associated with resistance to first-generation INSTIs, raltegravir (RAL) and elvitegravir (EVG). Here, we report the identification of mutations (G118R and E138K) which confer resistance to MK-2048 and not to RAL or EVG. These mutations were selected in vitro and confirmed by site-specific mutagenesis. G118R, which appeare  ...[more]

Similar Datasets

| S-EPMC7023979 | biostudies-literature
| S-EPMC5527620 | biostudies-literature
2020-01-01 | GSE113265 | GEO
| S-EPMC3302270 | biostudies-literature
| S-EPMC7187585 | biostudies-literature
| S-EPMC7850029 | biostudies-literature
| S-EPMC3265637 | biostudies-literature
| S-EPMC3069732 | biostudies-literature
| S-EPMC10121640 | biostudies-literature
| S-EPMC8829933 | biostudies-literature